Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

WHO Urges Higher Taxes on Tobacco, Alcohol, Sugary Drinks

The WHO urges governments to raise taxes on tobacco, alcohol, and sugary drinks, citing the growing chronic disease burden and strong public support for fiscal interventions.

Endocrine Therapy for All at High Risk for Breast Cancer?

Some say it’s ‘bad medicine’ not to be prescribing it more to high-risk patients, whereas others think alternative approaches might be better.

First Childbirth by Cesarean? Second May Need Fertility Help

Having a first child by cesarean delivery is linked to a reduced chance of having a second child and greater use of in vitro fertilization or other fertility treatments.

‘Phenomenal’ Tech May Boost Adenoma Detection in Colonoscopy

A recent study shows that real-time alerts telling physicians to adjust their gaze can help them find more adenomas per colonoscopy and improve polyp detection rates without increasing procedure time.

MHRA-NICE Pathway Aims to Speed Drug Access

A new pathway aligns MHRA approval with NICE appraisal, allowing guidance and authorisation to be issued together and speeding NHS access.

Mentally Active vs Passive Sitting May Lower Dementia Risk

Replacing mentally passive behaviors with mentally active ones while sedentary is associated with lower dementia risk in middle-aged and older adults, new research shows.

Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Latest News

The WHO urges governments to raise taxes on tobacco, alcohol, and sugary drinks, citing the growing chronic disease burden and strong public support for fiscal interventions.

Some say it’s ‘bad medicine’ not to be prescribing it more to high-risk patients, whereas others think alternative approaches might be better.

Having a first child by cesarean delivery is linked to a reduced chance of having a second child and greater use of in vitro fertilization or other fertility treatments.

A recent study shows that real-time alerts telling physicians to adjust their gaze can help them find more adenomas per colonoscopy and improve polyp detection rates without increasing procedure time.

A new pathway aligns MHRA approval with NICE appraisal, allowing guidance and authorisation to be issued together and speeding NHS access.

Replacing mentally passive behaviors with mentally active ones while sedentary is associated with lower dementia risk in middle-aged and older adults, new research shows.

News All Time

Be the Quarterback: How to Manage Stuttering in Children

Many pediatricians advise parents that children who stutter are going through a phase they’ll simply outgrow. Experts now believe a more active approach is needed.

Conference MDAngle: SGO 2026 Endometrial and Ovarian Cancer

Insights from SGO 2026, including anticipated presentations, key takeaways, and how emerging research in endometrial and ovarian cancer may affect patient care.

Long-Term PSA Screening Benefit: Modest but Real

Data over 23 years show a 13% drop in prostate cancer mortality. Dr Maurie Markman weighs the modest absolute benefit against the risks of overdiagnosis and overtreatment.

Episode 4: Secondary Hypertension and Sleep Apnea

Drs Marwah Abdalla and Susan Redline discuss when to suspect sleep apnea; how to approach screening, diagnosis, and treatment; and how it fits into hypertension management.

Iron Deficiency in Early Pregnancy Warns of Later Anemia

Iron deficiency without anemia in the first trimester is linked to an increased risk of developing anemia before childbirth.

Non-Risk-Based Lung Cancer Screening Tied to Better Survival

Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.

Esketamine Tied to ‘Rapid Response’ in Resistant Depression

Esketamine is associated with a 7-point reduction in symptoms of treatment-resistant depression at week 1, with nearly 50% of patients responding by week 4, in new research.

NSAIDs and Miscarriage: Not All Drugs Pose Equal Risk

The use of nonsteroidal anti-inflammatory drugs in early pregnancy is linked to an increased risk for miscarriage, with flurbiprofen showing the highest risk.

Constipation: Tips to Help Patients Find Relief

Not enough fiber and fluid is usually the culprit, but constipation can be caused by medications or disease processes.

Posttraumatic Headaches May Masquerade as Migraines

Migraine-like symptoms may affect up to 88% of adults with moderate-to-severe posttraumatic headache 2-4 months after mild traumatic brain injury, new research shows.

Myotonia Drug Gets Green Light for Pediatric Patients in EU

The European Medicines Agency has backed expanding Namuscla to address muscle rigidity in children and adolescents with rare inherited neuromuscular conditions.

No Link Between Common ADHD Treatment and Psychosis Risk

Methylphenidate, the most commonly prescribed treatment for ADHD, is not linked with increased psychosis risk and may even be protective in some patients, a new study shows.

Oral GLP-1s Beyond the Hype: The Polypharmacy Challenge

Oral weight-loss drugs bring great promise but require care in how they behave with other medications.

How Symptoms Affect Social Lives, Loneliness Near Life's End

Certain symptoms linked to loneliness.

Recommended News For You

Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients

Is Exercise an Effective Treatment for Prostate Cancer?

Scientists pioneer noninvasive 3D imaging to enhance skin cancer management

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.

Prostate cancer death risk is higher in late teens and early 20s weight gain.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

Recommended Articles For You

Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology 

Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer 

Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies 

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accurately identified high-grade prostate cancer through urine testing.

2.

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

3.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

4.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

5.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

1.

Radiation in Oncology: Advances, Applications, and Accessibility

2.

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer

3.

Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance

4.

The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025

5.

Demystifying Lymphocytes: Everything You Need to Know 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

4.

Navigating the Complexities of Ph Negative ALL - Part XII

5.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot